Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial-Reference-Cited by-同舟云学术

Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial

Published:2024-10 Issue:2 Volume:120 Page:422-431
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Zhang Qi,Fan Shaonan,Xu Xiaohong,Du Shisuo,Zhu Guangying,Jiang Chaoyang,Xia Shi-an,Li Qiwen,Wang Qifeng,Qian Dong,Zhang Ming,Xiao Han,Chen Gang,Zeng Zhaochong,He Jian

Funder

Fudan University

Zhongshan Hospital Fudan University

Publisher

Elsevier BV

Reference43 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

2. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

3. Dose escalation for non-small cell lung cancer: Analysis and modelling of published literature;Partridge;Radiother Oncol,2011

4. Radiation treatment time and overall survival in locally advanced non-small cell lung cancer;McMillan;Int J Radiat Oncol Biol Phys,2017

5. Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung cancer;Liao;J Clinl Oncol,2018